14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CCAP vs DXYZ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Destiny Tech100 Inc. (DXYZ) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (62.4/100 BUY vs. 19.6/100 STRONG SELL) after splitting the core matrix 6–4 (led by Growth & Scale, Options & Positioning), while CCAP wins 3–2 across the 6-pillar growth and valuation breakdown. CCAP trades at $10.08 (7.0x Forward P/E, 78.4% operating margin) versus DXYZ at $27.16 (N/M Forward P/E, 0.0% operating margin).
Growth vs. Quality Trade-Off: DXYZ earns the overall head-to-head edge with a stronger Unified Composite Score (62.4/100 BUY vs. CCAP 19.6/100 STRONG SELL) and 1.83β · 74% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3); meanwhile DXYZ is in a Breakdown options structure phase (RSI 48.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCAP vs DXYZ. Trailing 12-month operating profitability (CCAP 78.4% vs DXYZ 0.0%) and valuation multiples (CCAP 7.0x vs DXYZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Asset Management value chain with $1.2B market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CCAP vs DXYZ Key Questions & Quantitative Answers
As of Nov 16, 2026, Destiny Tech100 Inc. (DXYZ) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (62.4/100 BUY vs. 19.6/100 STRONG SELL) after splitting the core matrix 6–4 (led by Growth & Scale, Options & Positioning), while CCAP wins 3–2 across the 6-pillar growth and valuation breakdown. CCAP trades at $10.08 (7.0x Forward P/E, 78.4% operating margin) versus DXYZ at $27.16 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: DXYZ earns the overall head-to-head edge with a stronger Unified Composite Score (62.4/100 BUY vs. CCAP 19.6/100 STRONG SELL) and 1.83β · 74% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CCAP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.3); meanwhile DXYZ is in a Breakdown options structure phase (RSI 48.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DXYZ leads the Growth & Scale pillar: CCAP posts -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin), compared with DXYZ at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, CCAP generates $156M in USD-normalized revenue versus N/A for DXYZ. In operating R&D and SG&A reinvestment, CCAP deploys 21.6% of Rev ($34M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DXYZ.
CCAP screens cheaper on headline valuation multiples. CCAP trades at 7.0x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin), whereas DXYZ trades at N/M Forward P/E, 3.1x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCAP (-0.5% ROE) versus DXYZ (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk). By comparison, DXYZ carries 93.5% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.40x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.83β · 74% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.